Autopsy report · NCT05429788

Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Receptor Life Sciences
Sponsor type: Industry
Conditions: Social Anxiety Disorder
Interventions: Low dose RLS103; High dose RLS103; placebo inhaled dry powder
Participants: 0
Sites: 3
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.